Abstract
Serious and unexpected adverse events, such as heart failure and drug-induced lupus, have been reported in patients receiving TNF inhibitor therapy. These events generally are easily recognizable, although they cannot be predicted nor avoided, other than by drug avoidance altogether. Many patients have great benefit from anti-TNF therapies. Their intelligent use requires a firm understanding of these rare toxicities, so as to minimize the morbidity associated with their uncommon occurrence.
Original language | English (US) |
---|---|
Pages (from-to) | S141-S147 |
Journal | Clinical and experimental rheumatology |
Volume | 22 |
Issue number | 5 SUPPL. 35 |
State | Published - 2004 |
Keywords
- Congestive heart failure
- Drug-induced lupus
- Rheumatoid arthritis
- TNF inhibitors
ASJC Scopus subject areas
- Rheumatology
- Immunology and Allergy
- Immunology